Year: 2024
Type: article
Abstract: Hope for Dystrophic Hearts In article number 2305927, Hoe-Yune Jung, Johan Auwerx, and co-workers introduce cyclo histidineproline (CHP) as a new promising treatment for diverse myopathies, including the rare Duchenne muscular dystrophy (DMD) and the increasingly common age-related sarcopenia. The study shows that CHP improves muscle contractility and reduces fibrosis in DMD, while lessening muscle atrophy in aged mice. The cover portrays a collection of heart histological sections – with colors whimsically adjusted.
Source: Advanced Science
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $6,120
OpenAlex ID: W4400935690